CTOs on the Move

Symbiomix Therapeutics

www.symbiomix.com

 
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.symbiomix.com
  • 105 Lock Street Suite 409
    Newark, NJ USA 07103-3576
  • Phone: 609.722.7250

Executives

Name Title Contact Details

Funding

Symbiomix Therapeutics raised $41M on 05/06/2015

Similar Companies

Innomed

Innomed is a Savannah, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Portage Path Behavorial Health

Portage Path Behavorial Health is a Akron, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bartels

Bartels is a Issaquah, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Concentra Medical with Urgent Care

Concentra Medical with Urgent Care is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

International Guidelines Center

International Guidelines Center is a Catonsville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.